Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Real World Study on the Use of Low Dose Methoxyflurane (PENTHROX™) for the Treatment of Moderate to Severe Trauma Pain in the Canadian Emergency Department

NCT03868436 is registered in ClinicalTrials.gov with Purdue Pharma, Canada as lead sponsor.

NCT NCT03868436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Real World Study on the Use of Low Dose Methoxyflurane (PENTHROX™) for the Treatment of Moderate to Severe Trauma Pain in the Canadian Emergency Department
Lead sponsor
Purdue Pharma, Canada
Phase
Phase 4
Overall status
Completed
Start date
April 8, 2019
Completion date
September 8, 2020
Enrollment
99 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pain, acute